Share markets in India are presently trading near the dotted line. Sectoral indices are trading on a mixed note with stocks in the auto sector and consumer durable sector witnessing maximum buying interest. Stocks from the energy sector are trading in the red.
The BSE Sensex is trading up by 2 points, while the NSE Nifty is trading up by 4 points. The BSE Mid Cap index is trading down by 0.4%, while the BSE Small Cap index is trading down by 0.2%.
The rupee is trading at 68.77 to the US$.
In the news from the pharma sector, Suven Life Sciences share price is in focus today as the company secured 1 patent each from Mexico and New Zealand.
The new patents are corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases. The patents are valid through 2030 and 2036, respectively.
As per the news, the granted claims of the patents include the class of selective H3 and 5-HT4 compounds, respectively. Also, they are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia and sleep disorders like Narcolepsy.
At the time of writing, Suven Life Sciences share price was trading up by 1.3% on the BSE. Commenting on the above development, Venkat Jasti, CEO of Suven Life Sciences said that the management of the company is very pleased by the grant of these patents to Suven for its pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally.
Speaking of the pharma sector, note that the BSE Healthcare Index has been on a roller coaster ride in the past few years. The period from 2012 to 2015 saw the index go up more than three times.
